Body Composition and Quality of Weight Loss During Liraglutide 3.0 mg Therapy: Association with a Structured Exercise Programme
Background/Objectives: We evaluated changes in body composition, metabolic parameters, and quality of life during liraglutide 3.0 mg treatment within a multimodal obesity-management programme and explored their association with participation in structured exercise. Methods: This prospective, non-randomised, real-world...